Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the ...
Brooklyn Nets wing Cam Johnson is available for a deal, but it's possible he'll stay in town after Thursday's trade deadline.
Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...
Guggenheim maintained a Neutral rating on Johnson & Johnson (NYSE:JNJ) but increased the stock's price target from $162.00 to $166.00. The adjustment follows the release of the company's ...